The Science and Patents Behind Weight-Loss Drugs
Pulkit Vij of Remfry & Sagar made a presentation recently as part of the Firm's knowledge-sharing sessions discussing how the future is becoming lighter by the day!
Modern weight-loss drugs such as Ozempic and Mounjaro are transforming treatment paradigms and market dynamics alike. Pulkit unpacked how these therapies work, why they are surging in popularity, and the patent disputes shaping the sector - including Novo Nordisk’s matters before the Delhi High Court.
A fascinating intersection of science, business, and IP!
Disclaimer
As per the rules of the Bar Council of India, we are not permitted to solicit work or advertise in any manner. By proceeding further and clicking on “I Agree” below, the user acknowledges that the transmission, receipt or use of the information on our website does not tantamount to solicitation, advertisement, inducement or personal communication of any sort for and on behalf of the Firm so as to create an attorney-client relationship.
The information provided herein should not be interpreted as legal advice, for which the user must make independent inquiries. Whilst every effort has been taken to ensure the accuracy of the contents of this website, Remfry & Sagar disclaims all liability arising from reliance placed by the user or any other third party on the information contained therein.